Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!
Antibacterial Drugs Market - Global I...
Home  »  Community News  »  Antibacterial Drugs ...
Antibacterial Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023
Pharma News
, , , ,

NEW YORK, Jan. 7, 2016 /PRNewswire/ –This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs is segmented on the basis of major classes of drugs,namely,aminoglycosides,B-lactams, tetracyclines, sulfonamides, quinolones/fluoroquinolones, macrolides, phenicols and miscellaneous antibacterials. The market for each of these classes has been extensively analyzed on the basis of leading drug launch, patent expiry, drug efficacy, annual sales revenue and geography wise regulatory approval. The market size and forecast in terms of USD million for each of these classes has been provided for the period 2013 to 2023, considering 2013 and 2014 as the historical and base year respectively, while the market forecast has been provided for the period 2015 to 2023. The report on antibacterial drugs market also provides compounded annual growth rate (CAGR) for each market segment for the forecast period 2015 to 2023.

Geographically, the antibacterial drugs market has been categorized into five regions, namely, North America, Europe, Asia Pacific, Latin America and Rest of the World (ROW). Each of these geographies have been further segmented with respect to major countries; where North America is segmented in U.S. and Canada, Europe is segmented in U.K., Germany and rest of Europe, Asia Pacific is segmented in China, Japan and rest of Asia Pacific, and Latin America is segmented in Brazil and rest of Latin America. The report also comprises a section on pipeline analysis, which provides sales forecast for various drugs currently under phase III clinical trials and are expected to be launched during the forecast period. Forecast of seventeen pipeline drugs has been provided since their launch in the U.S., till 2023. Apart from the quantitative information, the report also provides details on various qualitative factors impacting the antibacterial market trends such as drug recalls, black box warning, changes in regulatory policies, drug patent expiry and subsequent launch of generics and others.

The research study also incorporates competitive scenario in the considered regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global antibacterial drugs market, and future opportunities has been provided in the market overview section. This section of the report also provides detailed market attractiveness analysis for major geographies. The analysis considers factors such as level of competition, interference of government and regulatory agencies, available customer base and future potential. The global antibacterial drugs market report includes a chapter on competitive landscape which provides market share analysis by leading players in the antibacterial drugs market, in terms of percent share in the year 2014. The report also includes event impact analysis, which provides a holistic view of new drug approvals in the market. A list of recommendations has also been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

The report also profiles major players in the antibacterial drugs market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include Allergen plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi.

The global antibacterial drugs market is segmented as follows:

Global Antibacterial Drugs Market, by Drug Class, 2013 – 2023 (USD Million)
Miscellaneous Antibacterials
Pipeline Analysis of Antibacterial Drugs Market
Actoxumab/Aezlotoxumab, (MK-3415A)
Surotomycin (MK-4261)
Ciprofloxacin/Fluocinolone Acetonide
Zempia (E-101)
Carbavance (meropenem/RPX7009)
Solithromycin (CEM-101)
Omadacycline (PTK-0796)
Global Antibacterial Drugs Market, by Geography, 2013 – 2023 (USD Million)
North America
Rest of Europe
Rest of Asia Pacific
Latin America
Rest of Latin America
Rest of the World (RoW)
Read the full report: http://www.reportlinker.com/p03147361-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


Leave a reply

You must be logged in to post a comment.